Medical/Pharmaceuticals
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
GUANGZHOU, China, May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II clinical trial of QA102 in patients with intermediate dry ...
2026-05-06 08:28
3065
Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026)
HONG KONG, May 6, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the 33rd European Congress on Obesity (ECO 2026), taking place May 12-15, 2026 in Istanbul, Türkiye. The presentations include a poster on...
2026-05-06 08:10
2460
Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
* PEDMARQSI® is now TGA registered in Australia for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid tumours * TGA registration provides an approved treatment option in an area of significant unmet me...
2026-05-06 05:01
2649
AI Model Analyses Body Composition to Predict Health Risks
OAK BROOK, Ill., May 5, 2026 /PRNewswire/ -- Researchers used AI to analyze whole-body MRI scans from more than 66,000 participants to create the most detailed reference map to date of how fat and muscle are distributed in the human body across age, sex and height. The study was published today i...
2026-05-05 22:00
2280
Hidden Muscle Fat Poses Danger to Heart, Metabolism
OAK BROOK, Ill., May 5, 2026 /PRNewswire/ -- Using a deep learning model to analyze the composition of large muscles on MRI, German researchers found that the proportions of intermuscular fat and lean muscle mass were associated with high blood pressure and unhealthy lipid and blood sugar levels....
2026-05-05 22:00
2183
BostonGene Receives Frost & Sullivan's 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Recognition highlights BostonGene's leadership in improving drug development
decisions,
reducing risk and accelerating patient impact
SAN ANTONIO, May 5, 2026 /PRNewswire/ -- Frost & Sullivan
2026-05-05 22:00
3196
3Shape appoints new Chief Financial Officer
COPENHAGEN, Denmark, May 5, 2026 /PRNewswire/ -- 3Shape today announced the appointment of Stefan Kratzer as Chief Financial Officer effective 5 May. He will join the Senior Leadership Team and report directly to CEO Jacob Paulsen. The appointment ensures strong leadership continuity, with an exp...
2026-05-05 19:26
2255
Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein - the Largest Known to Be Simulated with Quantum Computers
Milestone simulation of biologically meaningful molecules expands
quantum-centric supercomputing's role as a scientific tool
YORKTOWN HEIGHTS, N.Y. and CLEVELAND, May 5, 2026 /PRNewswire/ -- Scientists
at Cleveland Clinic, RIKEN, and IBM (NYSE:IBM
2026-05-05 12:18
3187
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with steroid-refractory GVHD HOUSTON, May 5, 2026 /PRNewswire/ -- Cellenkos®, Inc., a clinical stage biotechnology company, pioneering allogeneic, ...
2026-05-05 05:16
2619
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
MELBOURNE, Australia and INDIANAPOLIS, Ind., May 5, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the publication of a new independent analysis of Phase 3 ZIRCON trial data in European Urology[1], demonstrating that TLX250‑Px (Zircaix®[2], 89 Z...
2026-05-05 05:00
3088
CARiNG Pharmacy Introduces "Empowering Women, Inspiring Wellness" Campaign to Encourage Women to be More Proactive About Their Health
The new campaign focuses on a holistic approach to women's health by connecting inner wellness, outer wellbeing and mental health in everyday life KUALA LUMPUR, Malaysia, May 4, 2026 /PRNewswire/ -- CARiNG Pharmacy, together with Georgetown Pharmacy and Wellings Pharmacy under BIG CARING Group, h...
2026-05-04 16:04
4785
Olympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio
Partnership Aimed at Expanding Patient Access to Advanced EndoTherapeutic
Procedures
TOKYO, May 4, 2026 /PRNewswire/ -- Olympus Corporation
2026-05-04 15:00
4347
TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE
SINGAPORE, May 4, 2026 /PRNewswire/ -- Edwards Lifesciences, the leading global structural heart innovation company, recently announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were p...
2026-05-04 14:00
4002
XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
SHENZHEN, China, May 4, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading AI- and robotics-powered innovation platform, today announced dual breakthroughs in its strategic partnership with PharmaEngine (4162.TWO) PEP08, a next-generation PRMT5 inhibitor discovered via XtalPi's platform, has succes...
2026-05-04 08:19
3681
TLX101-Px (Pixlumi®) MAA Accepted in Europe
MELBOURNE, Australia and INDIANAPOLIS, May 1, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the marketing authorization application (MAA) filed in Europe for TLX101-Px (O-(2-[18F]fluoroethyl)-L-tyrosine, 18F-FET), its glioma (brain cancer...
2026-05-01 08:48
6135
Park Systems Launches NX1: The Highest Resolution AFM for Atomic-Scale Imaging in Ambient Conditions
GWACHEON, South Korea, April 30, 2026 /PRNewswire/ -- Park Systems Corp., the world's leading provider of atomic force microscopy (AFM) solutions, today announced the launch of the NX1 — a compact, high-performance AFM that delivers atomic resolution imaging in ambient conditions. Developed in co...
2026-04-30 20:44
3821
Malaysia Healthcare Strengthens Presence in Myanmar as Demand for Trusted Treatment Abroad Grows
KUALA LUMPUR, Malaysia, April 30, 2026 /PRNewswire/ -- For many patients in Myanmar, seeking medical care abroad is becoming an increasingly considered decision, particularly for specialised treatments, second opinions, and long-term health management. As healthcare awareness grows, more patients...
2026-04-30 16:43
4311
Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160
BEIJING, April 30, 2026 /PRNewswire/ -- Huahui Health today announced that it has entered into a global exclusive option, license and collaboration agreement with BeOne Medicines for HH160, a novel trispecific antibody in oncology immunotherapy. Under the agreement, BeOne Medicines is granted an ...
2026-04-30 16:28
5169
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
MAKATI CITY, Philippines, April 30, 2026 /PRNewswire/ -- Pfizer Philippines, together with healthcare professionals, has launched "For the Reasons that Matter", a public awareness campaign focused on adult respiratory health. Rolling out across the Philippines, Malaysia, Indonesia and Singapore, ...
2026-04-30 16:14
4973
Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, "Diagens"), a pioneer in medical imaging foundation models, today announced its first annual results since its listing. The report marks a pivotal milestone in the company's transition fr...
2026-04-30 13:18
5721
Week's Top Stories
Most Reposted
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
[Picked up by 331 media titles]
2026-05-05 10:01Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 313 media titles]
2026-05-06 12:00
AVPN AI Opportunity Fund Expands to Build AI-Ready Generations Across Asia by Empowering Educators and Youth Across Asia-Pacific
[Picked up by 298 media titles]
2026-05-05 09:00Colebrook Bosson Saunders Expands Flo X Multi Compatibility for Curved Ultrawide Monitors
[Picked up by 290 media titles]
2026-05-05 11:00
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 289 media titles]
2026-05-11 16:20
Most Read
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
2026-05-05 10:01
7993
Amadeus delivers solid Q1 2026 growth, and maintains commercial momentum
2026-05-08 18:30
7138
Massimo Group Launches Sentinel 770 HVAC as Part of Sentinel Product Line Targeting Approximately US$10 Million in 2026 Revenue
2026-05-06 21:20
6934
LightInTheBox to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
2026-05-06 20:00
6777
